Cointime

  • News
  • Insight
  • Currencies
  • Columns
  • Events
  • Bitcoin $115,113.64 +1.39%
  • Ethereum $4,161.25 +2.16%
  • BNB $1,171.88 +3.20%
  • Optimism $0.46 -0.55%
  • Arbitrum $0.33 +1.48%
  • Solana $200.13 +0.98%
  • Polygon $0.22 +2.77%
  • Cosmos $3.20 -0.74%
  • Avalanche $20.48 -0.21%
  • Bitcoin $115,113.64 +1.39%
  • Ethereum $4,161.25 +2.16%
  • BNB $1,171.88 +3.20%
  • Optimism $0.46 -0.55%
  • Arbitrum $0.33 +1.48%
  • Solana $200.13 +0.98%
  • Polygon $0.22 +2.77%
  • Cosmos $3.20 -0.74%
  • Avalanche $20.48 -0.21%
Home / Colossal Biosciences / investors

Colossal Biosciences

investment firm

Investors

Number of Lead Investors
Number of Investors
4
29
Colossal Biosciences is funded by 29 investors. In-Q-Tel and At One Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
In-Q-Tel Yes Series Unknown
At One Ventures Yes Series A
Thomas Tull Yes Series A
11:11 Media - Series A
Animal Capital - Series A
Animoca Brands - Series A
Bold Capital Partners - Series A
Boost VC - Series A
Breyer Capital - Series A
Builders VC - Series A
cFund - Series A
Charles Hoskinson - Series A
Draper Associates - Series A
First Light Capital - Series A
Green Sands Equity - Series A
Jazz Venture Partners - Series A
Milad Alucozai - Series A
Paris Hilton - Series A
Robert Nelsen - Series A
Untamed Planet - Series A
Capital Factory - Seed
Climate Capital - Seed
Global Space Ventures - Seed
Jeffrey Wilke - Seed
KittyHawk Ventures - Seed
Liquid 2 Ventures - Seed
Rayyan Islam - Seed
Tony Robbins - Seed
Winklevoss Capital - Seed

Highlights

Investments
4
Exits
0
Founders (Alumni)
0
Contacts
1

Contact

Dallas,Texas,United States
Cointime
Insight
  • Latest News
  • Web3
  • Blockchain
  • Metaverse
  • Bitcoin
  • Ethereum
  • NFT
  • DeFi
Features
  • Startups
  • Research
  • Technology
  • Topics
  • Columns
  • Currencies
  • Events
  • Tags
RSS
  • Latest News
  • Startups
  • Research
  • Technology
Company
  • About
  • Advertise
  • Disclaimers
  • © 2023 Cointime. All rights reserved.
  • Privacy Policy
  • Terms & Conditions